Itzhak Goldberg - 01 Dec 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Executive Chairman and Chief Scientific Officer, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Itzhak Goldberg
Issuer symbol
ELTX
Transactions as of
01 Dec 2021
Net transactions value
-$410,211
Form type
4
Filing time
03 Dec 2021, 17:03:34 UTC
Previous filing
17 Nov 2021
Next filing
07 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale $137,667 -38,867 -2.1% $3.54 1,831,201 01 Dec 2021 Direct F1, F2
transaction ELTX Common Stock Sale $136,328 -38,800 -2.1% $3.51 1,792,401 02 Dec 2021 Direct F1, F3
transaction ELTX Common Stock Sale $136,216 -40,215 -2.2% $3.39 1,752,186 03 Dec 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.31 to $3.79 inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.64 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.29 to $3.50 inclusive.

Remarks:

Executive Chairman and Chief Scientific Officer